In addition, high HSF2 expression was significantly related to a shorter PFS for patients with stages 1, 1+2 and 2+3, grades 2 and 3, and AJCC-T stage 1 and 2 HCC (Figure 3C). Here, HSF2 is linked to hepatocellular carcinoma.